27 June 2024
Kanabo Group
Plc
("Kanabo"
or the "Company")
Result of
AGM
Kanabo Group Plc (LSE:KNB), a
leading health tech company, announces that at the Annual General
Meeting ("AGM") held earlier today, eight resolutions were duly
passed. The numbers of votes for each resolution are presented
below:
|
Resolution (No. as noted on proxy form)
|
Total For (i)
|
Total Against
|
Withheld (ii)
|
|
|
No.
of votes
|
%
of
vote
|
No.
of votes
|
%
of
vote
|
No.
of votes
|
|
Resolution 1
|
226,464,519
|
99.86%
|
313,881
|
0.14%
|
129,393
|
|
Resolution 2
|
218,146,960
|
96.31%
|
8,339,516
|
3.68%
|
420,817
|
|
Resolution 3
|
226,331,517
|
99.83%
|
376,111
|
0.17%
|
200,165
|
|
Resolution 4
|
218,268,057
|
96.28%
|
8,436,008
|
3.72%
|
203,728
|
|
Resolution 5
|
216,203,853
|
95.36%
|
10,500,212
|
4.63%
|
203,728
|
|
Resolution 6
|
216,246,519
|
95.38%
|
10,457,546
|
4.61%
|
203,728
|
|
Resolution 7
|
226,256,746
|
99.80%
|
447,319
|
0.20%
|
203,728
|
|
Resolution 8
|
155,841,995
|
68.79%
|
70,696,796
|
31.21%
|
368,502
|
|
Resolution 9 (iii)
|
155,793,930
|
68.78%
|
70,707,021
|
31.%
|
406,342
|
(i)
The "For" Proxy vote includes those giving the Chair of the AGM
discretion
(ii)
A vote "Withheld" is not a vote in law and is not included in the
proxy votes "For" or "Against" the resolution
(iii)
Special resolution
The full text of the resolutions can
be found in the Notice of Annual General Meeting, which is
available on the Company's website at: https://www.kanabogroup.com/investors/
For
further information, please visit http://www.kanabogroup.com/ or
contact the following:
Enquiries:
|
Kanabo Group plc
Avihu Tamir, Chief Executive
Officer
Assaf Vardimon, Chief Financial
Officer
Ian Mattioli, Non-Executive Chair of the Board
|
via Peterhouse Capital
+44 (0)20
7469 0930
|
|
|
|
|
Peterhouse Capital Limited
(Financial
Adviser and Broker)
|
+44 (0)20
7469 0930
|
About Kanabo Group
Plc
Kanabo Group
Plc (LSE:KNB) is a healthtech company committed to
revolutionising patient care through its innovative technology
platform and disruptive product offerings. Since its inception in
2017, Kanabo has been focused on researching, developing, and
commercialising regulated medicinal cannabis-derived formulations
and therapeutic inhalation devices.
Kanabo's NHS-approved online
telehealth platform, The GP Service, provides patients with video
consultations, online prescriptions, and primary care services. The
Company is a leader in its field, focusing on improving patient
outcomes and providing more accessible healthcare
experiences.
In March 2023, Kanabo
successfully launched its Pain Clinic, Treat It, under the
expert guidance of its technological and product expertise. Treat
It initially focuses on chronic pain management using plant-based
medicine and treatments that are currently unavailable through
traditional channels.
At Kanabo Group Plc, we are
dedicated to providing patients with the highest quality medical
treatments and more accessible healthcare experiences.
Visit www.kanabogroup.com for
more information.